Pharmaceutical Imports, Commerce & CBP Tariffs & that dreaded number: “232”

Episode Summary:

In this episode, Benjamin L. England discusses recent developments in pharmaceutical imports, commerce, and CBP tariffs, particularly focusing on Section 232 investigations and reciprocal tariffs. The conversation covers the Department of Commerce's role in regulating international trade and its recent investigation into pharmaceutical imports.

 

Key Timestamps:

00:00 - Show Introduction

00:34 - Discussion of reciprocal tariffs and previous predictions

03:53 - China's retaliation and precious metals trade

05:22 - Department of Commerce's role in trade regulation

08:21 - How Commerce investigations are initiated

11:10 - Impact on pharmaceutical development and import/export

15:24 - Future predictions for international trade relations

 

About the Show:

FDA Imports Cross-Border Compliance with Attorney Benjamin L. England is a podcast that explores legal challenges, compliance issues, and regulations affecting global trade. The show provides expert insights into FDA-related products including foods, drugs, cosmetics, and medical devices.